Pristimerin is an triterpenoid and an antitumor agent. Induces caspase-dependent apoptosis by inhibiting the chymotrypsin-like activity of the proteasome. References: Deng Q, Bai S, Gao W, Tong L. Pristimerin inhibits angiogenesis in adjuvant-induced arthritic rats by suppressing VEGFR2 signaling pathways. Int Immunopharmacol. 2015 Dec;29(2):302-313. doi: 10.1016/j.intimp.2015.11.001. Epub 2015 Nov 6. PubMed PMID: 26548348.

纯度：≥98%

CAS：1258-84-0